Abstract
Systemic lupus erythematosus with neuropsychiatric involvement (NPSLE) can be diagnosed clinically, but there is no definite serological biomarker established. The objectives of this study were to evaluate the neuropsychiatric involvement in systemic lupus erythematosus (SLE) patients and to detect the autoantibodies associated with them. Sixty NPSLE patients along with sixty SLE patients without neuropsychiatric involvement from Maharashtra, India, were included. All patients were clinically diagnosed using the American College of Rheumatology criteria. Disease activity was assessed using the systemic lupus erythematosus disease activity index. Antinuclear antibodies (ANA), anti-dsDNA, anti-neuronal antibodies were detected by indirect immunofluorescence test. Anti-ribosomal antibodies (anti-Rib-P) were tested by ELISA. NPSLE was diagnosed in age group ranging between 10 and 20 years compared with SLE patients without neuropsychiatric involvement (21–30 years). The most frequent symptoms were psychosis (75 %), followed by seizures (58 %), lupus headache (40 %), cognitive dysfunction (36 %), mood disorder (30 %), cerebrovascular disease (20 %), and anxiety (18 %). ANA were present in all. The prevalence of anti-Rib-P was 26.6 % in NPSLE and 16.6 % in SLE patients without neuropsychiatric involvement. Anti-neuronal antibodies were found in 56.7 % in NPSLE and 43.4 % in SLE patients without neuropsychiatric involvement. Anti-neuronal antibodies were found to be highest in the patients of psychosis (66.6 %) followed by central nerve system disease (63.63 %) and seizures (56.25 %). There was an early onset of neuropsychiatric involvement. Anti-Rib-P antibodies as well as anti-neuronal antibodies did not show statistically significant correlation with neuropsychiatric manifestations in NPSLE patients.
Similar content being viewed by others
References
Shoenfeld Y, Szyper-Kravitz M, Witte T, Doria A, Tsutsumi A, Tatsuya A et al (2007) Autoantibodies against protective molecules–C1q, C-Reactive Protein, Serum Amyloid P, Mannose-Binding Lectin, and Apolipoprotein A1 Prevalence in Systemic Lupus Erythematosus. Ann NY Acad Sci 1108:227–239
Hanly JG (2004) ACR classification criteria for systemic lupus erythematosus: limitations and revisions to neuropsychiatric variables. Lupus 13(11):861–864
ACR Ad Hoc Committee on neuropsychiatric lupus nomenclature (1999) The American College of rheumatology nomenclature and case distribution for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599–608
Buća A, Perković D, Martinović-Kaliterna D, Vlastelica M, Titlić M (2009) Neuropsychiatric systemic lupus erythematosus: diagnostic and clinical features according to revised ACR criteria. Coll Andropov 33(1):281–288
Kimura A, Kanoh Y, Sakurai T, Koumura A, Yamada M, Hayashi Y, Tanaka Y, Hozumi I, Takemura M, Seishima M, Inuzuka T (2010) Antibodies in patients with neuropsychiatric systemic lupus erythematosus. Neurology 74(17):1372–1379
Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y (2009) Infections and autoimmunity–friends or foes? Trends Immunol 30(8):409–414
Zandman-Goddard G, Berkun Y, Barzilai O, Boaz M, Ram M, Anaya JM, Shoenfeld Y (2008) Neuropsychiatric lupus and infectious triggers. Lupus 17(5):380–384
Hochberg MC (1997) Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
Bombardier C, Gladmsn FF, Urowit MB, Caron D, Chang CH (1995) Derivation of SLEDAI: a disease activity index for lupus patients. The committee on prognosis studies in SLE. Arch Rheum 35: 630–640
Robert M, Sunitha R, Thulaseedharan N (2006) Neuropsychiatric manifestations systemic lupus erythematosus: a study from South India. Neurol India 54(1):75–77
Pradhan V, Patwardhan M, Rajadhyaksha A, Ghosh K (2012) Clinical and immunological profile of systemic lupus erythematosus. Indian Pediatrics 2012 Aug 5
Abdel-Nasser AM, Ghaleb RM, Mahmoud JA, Khairy W, Mahmoud RM (2008) Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus. Clin Rheumatol 27(11):1377–1385
Briani C, Lucchetta M, Ghirardello A, Toffanin E, Zampieri S, Ruggero S, Scarlato M, Quattrini A, Bassi N, Ermani M, Battistin L, Doria A (2009) Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study. J Autoimmun 32(2):79–84
Ebert T, Chapman J, Sheonfeld Y (2005) Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality? Lupus 14(8):571–575
Hussain N, Jaffery G, Hasnain S (2008) Association of ribosomal anti-P antibodies with different parameters of lupus. Afr J Biotechnol 7(24):4437–4440
Mostafa GA, Ibrahim DH, Shehab AA, Mohammed AK (2010) The role of measurement of serum autoantibodies in prediction of pediatric neuropsychiatric systemic lupus erythematosus. J Neuroimmunol 227(1–2):195–201
Hanly JG, Urowitz MB, Siannis F, Farewell V, Gordon C, Bae SC, Isenberg D et al (2008) Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum 58(3):843–853
Efthimiou P, Blanco M (2009) Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers. Mod Rheumatol 19(5):457–468
Mostafa G, Nazif H, El-Shahawi H, Abd El-Aziz M, Hassan M (2009) Antineuronal antibodies and electroneurophysiological studies in pediatric patients with neuropsychiatric systemic lupus erythematosus. Pediatr Allergy Immunol 20(2):192–199
How A, Peter B. Dent MD, Shuen-Kuei Liao MD, Dr. Judah A. Denburg MD. Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus. Arthritis and Rheumatism 1985:28: (7):789–795
Acknowledgments
We are grateful to the Director General, Indian Council of Medical Research (ICMR) and Director, National Institute of Immunohaematology, Mumbai, India, for allowing us to conduct this study in Indian SLE patients.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pradhan, V., Patwardhan, M., Rajadhyaksha, A. et al. Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India. Rheumatol Int 35, 541–545 (2015). https://doi.org/10.1007/s00296-014-3114-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-014-3114-z